Antimicrobial resistance

Antimicrobial Resistance (AMR)

The University of Leeds is committed to addressing the growing global challenge of antimicrobial resistance (AMR).

Our AMR research involves researchers from across our faculties in a wide range of disciplines. We work to coordinate, foster and promote these research efforts, with the aim of achieving the greatest impact.

What is AMR?

Antimicrobial agents, such as antibiotics, are our primary means of treating infectious diseases in humans and animals. Unfortunately, these drugs are rapidly becoming less effective, as microbes evolve to resist their effects, a phenomenon referred to as antimicrobial resistance or AMR.

In 2019, over 1.27million global deaths were attributed to AMR. If we don’t address this problem as a matter of urgency, over 300 million people worldwide are predicted to die prematurely by 2050.

Our research

Events and activities